Premium
Intravitreal steroids to treat the RVO‐associated macular edema
Author(s) -
CREUZOT C
Publication year - 2013
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2013.2714.x
Subject(s) - medicine , macular edema , glaucoma , edema , ophthalmology , surgery , retinal
Intravitreal steroids are interesting tools to treat macular edema associated to RVO. The effect of the treatment lasts approximately 4‐5 months. The main risk is increased ocular pressure ranging from 15% to 50% according to the type of steroids. Patients with glaucoma treated with at least two medications or unbalanced glaucoma will be treated with another therapeutic option to avoid complications. The regular follow‐up of the patient will define efficacy and safety of the treatment. For re injections, the rythm of control can be slightly eased.Commercial interest